<?xml version="1.0" encoding="UTF-8"?>
<p>EV-A71 seroprevalence was higher in the primary school 7–12 years age group (71.6%, 95% CI 68.2–74.7%) compared to the preschool 1–6 years age group (52.8%, 95% CI 49.8–55.9%; 
 <italic>P</italic>&lt;0.001) overall, and in 16 out of the 18 years analyzed (significantly different in 3 years; 
 <xref ref-type="supplementary-material" rid="pntd.0004562.s003">S3 Table</xref>). The overall seroprevalence and GMT were significantly higher in epidemic years (seroprevalence 67.4%, 95% CI 63.8–70.9%; GMT 23.6, 95% CI 21.8–25.5) compared to non-epidemic years (seroprevalence 56.6%, 95% CI 53.6–59.5%; GMT 17.8, 95% CI 16.7–19.0; 
 <italic>P</italic>&lt;0.001) (
 <xref ref-type="fig" rid="pntd.0004562.g003">Fig 3</xref>). During epidemic years, the seroprevalence of children aged 1–2 years (52.5%, 95% CI 44.8–60.0%), 3–5 years (66.1%, 95% CI 58.7–72.8%), and 6–9 years (75.4%, 95% CI 69.1–80.8%) were significantly higher compared to non-epidemic years (1–2 years old: 39.6%, 95% CI 33.9–45.5%; 3–5 years old: 51.6%, 95% CI 45.8–57.4%; and 6–9 years: 64.4%, 95% CI 59.1–69) (
 <xref ref-type="fig" rid="pntd.0004562.g003">Fig 3A</xref>). GMT also rose significantly during epidemic years (3–5 years old: 23.3, 95% CI 19.8–27.3; 6–9 years: 26.7, 95% CI 23.4–30.4; and 10–12 years old: 28.0, 95% CI 23.5–33.4) compared to non-epidemic years (3–5 years old: 18.1, 95% CI 15.7–20.9; 6–9 years: 18.1, 95% CI 16.2–20.2; and 10–12 years old: 20.4, 95% CI 18.0–23.1) (
 <xref ref-type="fig" rid="pntd.0004562.g003">Fig 3B</xref>).
</p>
